Insulin Pump Therapy in Nursing Practice: Patient Education, Glycemic Monitoring, and Clinical Safety

Sultan Falah Sultan Al-Qahtani; Zahrah Hussein Shabani; Mada Mohammad Al-Otaibj; Zahra Mesfer Summan Al Fayi; Shaykhah Rasheed Binmozan; Manal Ghazi Alharthi; Khulud Abdullah Aldosseri; Areej Mahboub Al Samti; Badr Talal Boydr Alanizi

doi:10.64483/202522393

Sultan Falah Sultan Al-Qahtani ⁽¹⁾, Zahrah Hussein Shabani ⁽²⁾, Mada Mohammad Al-Otaibj ⁽¹⁾, Zahra Mesfer Summan Al Fayi ⁽¹⁾, Shaykhah Rasheed Binmozan ⁽³⁾, Manal Ghazi Alharthi ⁽³⁾, Khulud Abdullah Aldosseri ⁽¹⁾, Areej Mahboub Al Samti ⁽¹⁾, Badr Talal Boydr Alanizi ⁽⁴⁾

(1) Badr 3 Primary Health Care Center,Ministry of Health, Saudi Arabia,

(2) Badr 3 Health Center,Ministry of Health, Saudi Arabia,

(3) Cluster 1, Riyadh – Badr 3,Ministry of Health, Saudi Arabia,

(4) Ministry of Education – Prince University, Saudi Arabia

https://doi.org/10.64483/202522393

Issue
Vol. 2 No. 2 (2025)

Submitted
December 27, 2025

Published
December 30, 2025

Keywords:

Insulin pump therapy, continuous subcutaneous insulin infusion, glycemic control, nursing education, diabetes management, patient safety.

PDF

Abstract

Background: Diabetes mellitus affects over 500 million people globally, with type 1 diabetes requiring lifelong insulin therapy. Insulin pump therapy, or continuous subcutaneous insulin infusion (CSII), has evolved as a cornerstone for intensive insulin management, offering improved glycemic control and flexibility compared to multiple daily injections.

Aim: To explore the clinical significance, operational principles, and nursing interventions associated with insulin pump therapy, emphasizing patient education and safety.

Methods: A comprehensive review of historical developments, device components, insulin delivery mechanisms, and evidence-based nursing practices was conducted, integrating clinical trials and guidelines to outline best practices for inpatient and outpatient care.

Results: CSII improves glycemic control, reduces hypoglycemia risk, and enhances patient satisfaction. Advanced features such as bolus calculators, auto-mode algorithms, and predictive low-glucose suspend systems further optimize outcomes. However, therapy introduces risks including infusion-site complications, rapid-onset hyperglycemia, and diabetic ketoacidosis during delivery interruptions. Nursing interventions—such as structured education, infusion-site monitoring, and contingency planning—are critical for safety.

Conclusion: Insulin pump therapy represents a clinically significant advancement in diabetes care, requiring interprofessional collaboration and vigilant nursing oversight to maximize benefits and minimize risks.

Full text article

Generated from XML file

References

Bratke H, Margeirsdottir HD, Assmus J, Njølstad PR, Skrivarhaug T. Does Current Diabetes Technology Improve Metabolic Control? A Cross-Sectional Study on the Use of Insulin Pumps and Continuous Glucose Monitoring Devices in a Nationwide Pediatric Population. Diabetes therapy : research, treatment and education of diabetes and related disorders. 2021 Sep:12(9):2571-2583. doi: 10.1007/s13300-021-01127-6.

Marks BE, Wolfsdorf JI, Waldman G, Stafford DE, Garvey KC. Pediatric Endocrinology Trainees' Education and Knowledge About Insulin Pumps and Continuous Glucose Monitors. Diabetes technology & therapeutics. 2019 Mar:21(3):105-109. doi: 10.1089/dia.2018.0331.

Sebastian SA, Co EL, Mehendale M, Hameed M. Insulin analogs in the treatment of type II diabetes and future perspectives. Disease-a-month : DM. 2023 Mar:69(3):101417. doi: 10.1016/j.disamonth.2022.101417.

Tremblay ES. Persistent Socioeconomic Disparities in Insulin Pump Uptake Despite Universal Health Coverage-Nonmonetary Drivers in Insulin Pump Use. JAMA network open. 2022 May 2:5(5):e2210471. doi: 10.1001/jamanetworkopen.2022.10471.

Lane WS, Weinrib SL, Lawrence MJ, Lane BC, Jarrett RT. Basal Insulin Degludec and Glycemic Control Compared to Aspart Via Insulin Pump in Type 1 Diabetes (BIGLEAP): A Single-Center, Open-Label, Randomized, Crossover Trial. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2022 Feb:28(2):165-172. doi: 10.1016/j.eprac.2021.11.001.

Deberles E, Morello R, Hardouin J, Amadou C, Benhamou PY, Prévost G, Schaepelynck P, Chaillous L, Joubert M, Reznik Y. The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort survey. Diabetes & metabolism. 2022 May:48(3):101300. doi: 10.1016/j.diabet.2021.101300.

Kamecke U, Waldenmaier D, Haug C, Ziegler R, Freckmann G. Establishing Methods to Determine Clinically Relevant Bolus and Basal Rate Delivery Accuracy of Insulin Pumps. Journal of diabetes science and technology. 2019 Jan:13(1):60-67. doi: 10.1177/1932296818788349.

Weaver KW, Hirsch IB. The Hybrid Closed-Loop System: Evolution and Practical Applications. Diabetes technology & therapeutics. 2018 Jun:20(S2):S216-S223. doi: 10.1089/dia.2018.0091.

Herrero P, Pesl P, Bondia J, Reddy M, Oliver N, Georgiou P, Toumazou C. Method for automatic adjustment of an insulin bolus calculator: in silico robustness evaluation under intra-day variability. Computer methods and programs in biomedicine. 2015 Apr:119(1):1-8. doi: 10.1016/j.cmpb.2015.02.003.

Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L, Waugh N. Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health technology assessment (Winchester, England). 2010 Feb:14(11):iii-iv, xi-xvi, 1-181. doi: 10.3310/hta14110.

Metwally M, Cheung TO, Smith R, Bell KJ. Insulin pump dosing strategies for meals varying in fat, protein or glycaemic index or grazing-style meals in type 1 diabetes: A systematic review. Diabetes research and clinical practice. 2021 Feb:172():108516. doi: 10.1016/j.diabres.2020.108516.

Rosales N, De Battista H, Vehí J, Garelli F. Open-loop glucose control: Automatic IOB-based super-bolus feature for commercial insulin pumps. Computer methods and programs in biomedicine. 2018 Jun:159():145-158. doi: 10.1016/j.cmpb.2018.03.007.

Grassi B, Onetto MT, Zapata Y, Jofré P, Echeverría G. Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile. Diabetes & metabolic syndrome. 2021 May-Jun:15(3):695-701. doi: 10.1016/j.dsx.2021.03.017.

Berg AK, Nørgaard K, Thyssen JP, Zachariae C, Hommel E, Rytter K, Svensson J. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study. Diabetes technology & therapeutics. 2018 Jul:20(7):475-482. doi: 10.1089/dia.2018.0088.

Dogan ADA, Jørgensen UL, Gjessing HJ. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion. Journal of diabetes science and technology. 2017 May:11(3):631-632. doi: 10.1177/1932296816668375.

Karges B, Schwandt A, Heidtmann B, Kordonouri O, Binder E, Schierloh U, Boettcher C, Kapellen T, Rosenbauer J, Holl RW. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes. JAMA. 2017 Oct 10:318(14):1358-1366. doi: 10.1001/jama.2017.13994.

Faulds ER, Wyne KL, Buschur EO, McDaniel J, Dungan K. Insulin Pump Malfunction During Hospitalization: Two Case Reports. Diabetes technology & therapeutics. 2016 Jun:18(6):399-403. doi: 10.1089/dia.2015.0434.

DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ, Dutch Insulin Pump Study Group. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes care. 2002 Nov:25(11):2074-80

Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la Calle H, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB, 5-Nations Study Group. Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabetic medicine : a journal of the British Diabetic Association. 2006 Feb:23(2):141-7

McAuley SA, Vogrin S, Lee MH, Paldus B, Trawley S, de Bock MI, Abraham MB, Bach LA, Burt MG, Cohen ND, Colman PG, Davis EA, Hendrieckx C, Holmes-Walker DJ, Jenkins AJ, Kaye J, Keech AC, Kumareswaran K, MacIsaac RJ, McCallum RW, Sims CM, Speight J, Stranks SN, Sundararajan V, Ward GM, Jones TW, O'Neal DN, Australian JDRF Closed-Loop Research Group. Less Nocturnal Hypoglycemia but Equivalent Time in Range Among Adults with Type 1 Diabetes Using Insulin Pumps Versus Multiple Daily Injections. Diabetes technology & therapeutics. 2021 Jun:23(6):460-466. doi: 10.1089/dia.2020.0589

Petrelli F, Cangelosi G, Scuri S, Pantanetti P, Lavorgna F, Faldetta F, De Carolis C, Rocchi R, Debernardi G, Florescu A, Nittari G, Sagaro GG, Garda G, Nguyen CTT, Grappasonni I. Diabetes and technology: A pilot study on the management of patients with insulin pumps during the COVID-19 pandemic. Diabetes research and clinical practice. 2020 Nov:169():108481. doi: 10.1016/j.diabres.2020.108481.

Zhang ZY, Miao LF, Qian LL, Wang N, Qi MM, Zhang YM, Dang SP, Wu Y, Wang RX. Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications. Frontiers in endocrinology. 2019:10():640. doi: 10.3389/fendo.2019.00640.

Zhang L, Leng X, Tian F, Xiao D, Xuan J, Yang H, Liu J, Chen Z. Cost-effectiveness analysis of continuous subcutaneous insulin infusion versus multiple daily insulin for treatment of children with type 1 diabetes. Postgraduate medicine. 2022 Aug:134(6):627-634. doi: 10.1080/00325481.2022.2088938.

Li Q, Wang L, Xiao L, Wang Z, Wang F, Yu X, Yan S, Wang Y. Effect of intensive insulin therapy on first-phase insulin secretion in newly diagnosed type 2 diabetic patients with a family history of the disease. Experimental and therapeutic medicine. 2015 Feb:9(2):612-618

Morros-González E, Gómez AM, Henao Carrillo DC, Ursida V, Serrano S, Rondón Sepúlveda MA, Muñoz Velandia OM. Efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in older adults: A retrospective study in Bogota, Colombia. Diabetes & metabolic syndrome. 2021 May-Jun:15(3):649-653. doi: 10.1016/j.dsx.2021.02.029.

O'Malley G, Ozaslan B, Levy CJ, Castorino K, Desjardins D, Levister C, McCrady-Spitzer S, Church MM, Kaur RJ, Reid C, Kremers WK, Doyle FJ, Trinidad MC, Rosenn B, Pinsker JE, Kudva YC, Dassau E. Longitudinal Observation of Insulin Use and Glucose Sensor Metrics in Pregnant Women with Type 1 Diabetes Using Continuous Glucose Monitors and Insulin Pumps: The LOIS-P Study. Diabetes technology & therapeutics. 2021 Dec:23(12):807-817. doi: 10.1089/dia.2021.0112.

Alemzadeh R, Palma-Sisto P, Holzum M, Parton E, Kicher J. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus. Diabetes technology & therapeutics. 2007 Aug:9(4):339-47

Umpierrez GE, Klonoff DC. Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes care. 2018 Aug:41(8):1579-1589. doi: 10.2337/dci18-0002.

Vettoretti M, Facchinetti A. Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review. Biomedical engineering online. 2019 Mar 29:18(1):37. doi: 10.1186/s12938-019-0658-x.

Yeh T, Yeung M, Mendelsohn Curanaj FA. Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear. Current diabetes reports. 2021 Jan 15:21(2):7. doi: 10.1007/s11892-021-01375-7.